Milk may help prevent potentially dangerous bacteria like Staphylococcus from being killed by antibiotics used to treat animals, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
Bacteria sometimes form structures called biofilms that protect them against antibiotics and the body's natural defences. Now scientists have discovered that one of the most important micro-organisms that causes mastitis in cows and sheep, called Staphylococcus, can evade the animal's defences and veterinary medicines by forming these protective biofilms. Mastitis is an infection of the udder in cattle and sheep. It is often a painful condition for the cows and can even cause death.
"Mastitis is a difficult disease to control. It causes risks for public health if people drink infected milk and is expensive for farmers as it usually causes severe milk production losses, increased treatment costs and means the animals may have to be culled," said Dr Manuela Oliveira from the Faculty of Veterinary Medicine at the Technical University of Lisbon, Portugal. "When the staphylococci produce a biofilm, the structure protects them against host defences and antibiotic treatment, allowing the bacteria to persist in the udder."
In the past, scientists studying mastitis have conducted most of their experiments under laboratory conditions rather than mimicking the conditions found in living animals. This may mean that they have missed important contributory factors. However, Dr Oliveira and her colleagues have used realistic conditions to overcome this problem.
"We have discovered that milk may also protect bacteria against low concentrations of antibiotics – in the presence of milk, three of the five antibiotics tested, penicillin, gentamicin and sulphamethoxazole combined with trimethoprim, were less effective against Staphylococcus when compared with the same experiment performed in the absence of milk," said Dr Oliveira.
Read the full article here.
No comments:
Post a Comment